Therapy Area Hub

Nephrology

Nephrology guidance, renal trial intelligence and drug mechanisms across chronic kidney disease, cardiorenal care and specialist prescribing.

1 Guidelines 0 Trials 0 News 3 Mechanisms

Education Hub Follow this Specialty

Clinical Intelligence

Latest Guidelines

View all 1

ERA30 Mar 2026

2022 ERA Guidelines on the Management of Chronic Kidney Disease

This ERA guideline addresses 2022 ERA Guidelines on the Management of Chronic Kidney Disease in Nephrology. Use it to review current recommendation wording, eligibility criteria, and…

Independent Editorial Public / open access

Drug Science

Relevant Mechanisms

Open library

Mechanism

Complement C5 Pathway

Complement C5 Pathway is a clinically relevant Drug Science explainer. The complement system comprises over 30 proteins forming a proteolytic…

Mechanism

RAAS Pathway

RAAS Pathway is a clinically relevant Drug Science explainer. The renin-angiotensin-aldosterone system (RAAS) is a hormonal cascade governing blood pressure,…

Mechanism

SGLT-2 Inhibition

SGLT-2 Inhibition is a clinically relevant Drug Science explainer. Sodium-glucose cotransporter-2 (SGLT-2) is a high-capacity, low-affinity transporter expressed almost exclusively…

Education

CPD, Podcasts & Webinars

Education hub

cpd module

Prescribing in Renal Impairment — Practical Guide

Classify chronic kidney disease stage using eGFR and recognise when renal impairment changes prescribing risk. Apply practical dose-adjustment…

Stay Updated

Follow Nephrology safety updates

Get MHRA safety alerts and clinically relevant updates for this specialty in your ClinicaliQ digest.

Set Safety Preferences →

Stay Updated

Follow Nephrology

Choose guideline, trial, Drug Science and education updates for this specialty.

Set Specialty Preferences →